Premium Phosphosite-Specific 7TM Antibodies
Novel Tools for Your GPCR Research
Select Your Country of Delivery below

Apelin Receptor Antibodies

Close filters
No results were found for the filter!
NEW
Agonist-induced Serine347/Serine348 phosphorylation of the Apelin Receptor
pS347/pS348-APLNR (phospho-Apelin Receptor...
Serine347/Serine348 (S347/S348) is major phosphorylation site of the Apelin Receptor (APLNR). The pS347/pS348-APLNR antibody detects phosphorylation in response to agonists. S347/S348 phosphorylation is likely to be involved in efficient...
$ 375.00 *
Details

Apelin Receptor

The apelin receptor (APLNR) responds to apelin, a 36 amino-acid peptide which is cleaved from a 77 amino-acid precursor peptide. Apelin-36, apelin-13 and [Pyr1]apelin-13 are the predominant endogenous ligands. A second family of peptides named Elabela/Toddler has discovered independently as endogenous ligands. The capelin receptor is coupled to inhibitory G-proteins. A number of physiological roles for the receptor have emerged, including regulation of cardiovascular function, fluid homeostasis, the adipoinsular axis, gastrointestinal and immunomodulatory functions. APLNR receptor desensitization, β-arrestin recruitment and internalization are regulated by phosphorylation of carboxyl-terminal serine347/serine348 (pS347/pS348-APLNR). This nomenclature refers to human APLNR. This phosphorylation motif is highly conserved across species but corresponds to pS345/pS346-APLNR in mice and rats. For more information on APLNR pharmacology please refer to the IUPHAR database. For further reading refer to:

Pitkin SL, Maguire JJ, Bonner TI, Davenport AP. International Union of Basic and Clinical Pharmacology. LXXIV. Apelin receptor nomenclature, distribution, pharmacology, and function. Pharmacol Rev. 2010 Sep;62(3):331-42. doi: 10.1124/pr.110.002949. Epub 2010 Jul 6. PMID: 20605969.

The apelin receptor (APLNR) responds to apelin, a 36 amino-acid peptide which is cleaved from a 77 amino-acid precursor peptide. Apelin-36, apelin-13 and [Pyr1]apelin-13 are the predominant... read more »
Close window
Apelin Receptor Antibodies

Apelin Receptor

The apelin receptor (APLNR) responds to apelin, a 36 amino-acid peptide which is cleaved from a 77 amino-acid precursor peptide. Apelin-36, apelin-13 and [Pyr1]apelin-13 are the predominant endogenous ligands. A second family of peptides named Elabela/Toddler has discovered independently as endogenous ligands. The capelin receptor is coupled to inhibitory G-proteins. A number of physiological roles for the receptor have emerged, including regulation of cardiovascular function, fluid homeostasis, the adipoinsular axis, gastrointestinal and immunomodulatory functions. APLNR receptor desensitization, β-arrestin recruitment and internalization are regulated by phosphorylation of carboxyl-terminal serine347/serine348 (pS347/pS348-APLNR). This nomenclature refers to human APLNR. This phosphorylation motif is highly conserved across species but corresponds to pS345/pS346-APLNR in mice and rats. For more information on APLNR pharmacology please refer to the IUPHAR database. For further reading refer to:

Pitkin SL, Maguire JJ, Bonner TI, Davenport AP. International Union of Basic and Clinical Pharmacology. LXXIV. Apelin receptor nomenclature, distribution, pharmacology, and function. Pharmacol Rev. 2010 Sep;62(3):331-42. doi: 10.1124/pr.110.002949. Epub 2010 Jul 6. PMID: 20605969.

Recently viewed